Drugs commonly used to treat prostate cancer might increase the risk of heart disease and diabetes, indicating the treatments should be used more judiciously, researchers reported Monday.
More: continued here
Cancer researchers have found that a gene that is involved in regulating aging also blocks prostate cancer cell growth. They have shown that the enzyme SIRT1 can block the growth of treatment-resistant prostate cancer cells that overexpress a mutation for the androgen receptor. The scientists hope the newly found connection will aid in better understanding the development of prostate cancer and lead to new drugs against the disease.
More: continued here
(WebMD) When it comes to hormone therapy for prostate cancer, more may not always be better. A new study suggests some men who take the drugs for more than six months do not live as long as those who …
More: continued here
